SCHEDULE 13G Filed 2026-09-21 Event — SEC 0001732748-26-000003 →

MOLL PETER → Werewolf Therapeutics, Inc. HOWL

Stake: — Shares: — Class: Common stock 0,0001$ per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 3.70

2,511,400 shares short · +47.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $9K

Point72 Asset Mgmt

Other 13D/G Filings on Werewolf Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-02	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	4.10%	1,985,541	view →
2026-06-26	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	6.00%	2,915,742	view →
2026-06-22	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	3,654,307	view →
2026-06-15	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	5,138,703	view →
2026-05-14	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	6,116,140	view →
2025-12-29	SCHEDULE	MPM BioVentures 2014, L.P.	8.20%	3,977,612	view →
2025-05-14	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	15.00%	6,746,807	view →
2022-08-12	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2021-06-16	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →